tiprankstipranks
Trending News
More News >

Brian Cheng Profile - J.P. Morgan Analyst

67 Followers
tipranks
Brian Cheng

Brian Cheng
J.P. Morgan

Wall Street Analyst
#9,325 out of 10,123 Wall Street Analysts
#32,683 out of 42,330 experts

Success Rate

47%
74 out of 158 ratings made a profit

Average Return

-5.30%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Brian Cheng's trades since 2019 and holding each position for 1 Year would result in 46.84% of your transactions generating a profit, with an average return of -5.3% per rating.

Stock Rating Distribution

220Ratings
78.64% Buy
13.64% Hold
7.73% Sell
Distribution of Brian Cheng's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
ProQR Therapeutics BV
(PRQR)
Rating:Buy
Date:Apr 19, 2022 - Apr 19, 2023
Return:+193.40%
The most profitable rating made by Brian Cheng

Brian Cheng's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Apellis Pharmaceuticals
Dec 19, 2019
Buy
Initiated
$36.00
(85.09% Upside)
1Ratings
100%
+80.00%
ALLK
Allakos
Oct 15, 2021
Buy
Reiterated
$218.00
(66141.26% Upside)
1Ratings
0%
-94.40%
RGLS
Regulus
Oct 18, 2021
Buy
Reiterated
$20.00
(145.10% Upside)
2Ratings
0%
-74.75%
HARP
Harpoon Therapeutics
Oct 27, 2021
Buy
Reiterated
2Ratings
0%
-85.60%
Equillium
Nov 02, 2021
Buy
Reiterated
$14.00
(1286.14% Upside)
2Ratings
0%
-71.00%
SRRA
Sierra Oncology
Nov 30, 2021
Buy
Reiterated
3Ratings
0.00%
PSTX
Poseida Therapeutics
Feb 18, 2022
Buy
Reiterated
$24.00
(152.63% Upside)
2Ratings
100%
+40.45%
Arcturus Therapeutics
Mar 01, 2022
Buy
Reiterated
$86.00
(1323.84% Upside)
5Ratings
0%
-52.08%
Lucid Diagnostics
Apr 04, 2022
Buy
Reiterated
$12.00
(1076.47% Upside)
1Ratings
0%
-62.20%
BioCryst
Apr 08, 2022
Buy
Reiterated
$17.00
(145.31% Upside)
6Ratings
0%
-17.50%
List of latest recommendations made by Brian Cheng. Click to expand and see Brian Cheng's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Brian Cheng activity FAQ

What is the performance of Brian Cheng's recommendations?
The percentage of profitable recommendations made by Brian Cheng is 47%, and the average return per transaction is -5.30%.
    What stocks does Brian Cheng cover?
    Brian Cheng mostly covers ROIV ,PTGX ,NTLA stocks.
      What was Brian Cheng's most profitable rating?
      Brian Cheng’s most profitable ratings was a buy on PRQR stock on Apr 19, 2022 - Apr 19, 2023. The return on the trade was +193.40%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here